(1)
Balapadang, R. N.; Sudarjat, H. Potential of Beta-Hydroxybutyrate (BHB) in the Management of Type 2 Diabetes and Risk of Ketoacidosis in Diabetic Patients. JPS 2024, 7, 562-570.